The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels

Annals of Surgical Oncology

Volumn 19, Issue 8, 2012, Pages 2590-2599

  Peppone, Luke J ^a   Rickles, Aaron S ^a   Janelsins, Michelle C ^a   Insalaco, Michael R ^a   Skinner, Kristin A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CASE STUDY; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; TRIPLE NEGATIVE BREAST CANCER; VITAMIN BLOOD LEVEL;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84865037333     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2297-3     Document Type: Article

References (32)

1. K Townsend CM Banwell M Guy KW Colston JL Mansi PM Stewart, et al. 2005 Autocrine metabolism of vitamin D in normal and malignant breast tissue Clin Cancer Res 11 3579 3586 15867263 10.1158/1078-0432.CCR-04-2359 1:CAS:528:DC%2BD2MXjslOqtbg%3D
2. PJ Goodwin M Ennis KI Pritchard J Koo N Hood 2009 Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer J Clin Oncol 27 3757 3763 19451439 10.1200/JCO.2008.20.0725 1:CAS:528:DC%2BD1MXhtFaitr3K
3. T Gissel L Rejnmark L Mosekilde P Vestergaard 2008 Intake of vitamin D and risk of breast cancer-a meta-analysis J Steroid Biochem Mol Biol 111 195 199 18590821 10.1016/j.jsbmb.2008.06.002 1:CAS:528:DC%2BD1cXhtVamtLfK
4. ER Bertone-Johnson WY Chen MF Holick BW Hollis GA Colditz WC Willett, et al. 2005 Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer Cancer Epidemiol Biomarkers Prev. 14 1991 1997 16103450 10.1158/1055-9965.EPI-04-0722 1:CAS:528:DC%2BD2MXnsl2ksLc%3D
5. J Lin JE Manson IM Lee NR Cook JE Buring SM Zhang 2007 Intakes of calcium and vitamin D and breast cancer risk in women Arch Intern Med 167 1050 1059 17533208 10.1001/archinte.167.10.1050 1:CAS:528:DC%2BD2sXmvVGrtLY%3D
6. ML Neuhouser B Sorensen BW Hollis A Ambs CM Ulrich A McTiernan, et al. 2008 Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors Am J Clin Nutr 88 133 139 18614733 1:CAS:528:DC%2BD1cXoslylsb8%3D
7. Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, et al. Pretreatment serum concentrations of 25-hydroxyvitamin d and breast cancer prognostic characteristics: a case-control and a case-series study. PLoS One. 2011;6:e17251.
8. C Palmieri T MacGregor S Girgis D Vigushin 2006 Serum 25-hydroxyvitamin D levels in early and advanced breast cancer J Clin Pathol 59 1334 1336 17046848 10.1136/jcp.2006.042747 1:CAS:528:DC%2BD2sXhtVOhs70%3D
9. S Abbas J Linseisen T Slanger S Kropp EJ Mutschelknauss D Flesch-Janys, et al. 2008 Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study Carcinogenesis 29 93 99 17974532 10.1093/carcin/bgm240 1:CAS:528:DC%2BD1cXhs1aisrk%3D
10. LC Lowe M Guy JL Mansi C Peckitt J Bliss RG Wilson, et al. 2005 Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population Eur J Cancer 41 1164 1169 15911240 10.1016/j.ejca.2005.01.017 1:CAS:528:DC%2BD2MXks1Gjtrs%3D
11. P Chen P Hu D Xie Y Qin F Wang H Wang 2010 Meta-analysis of vitamin D calcium and the prevention of breast cancer Breast Cancer Res Treat 121 469 477 19851861 10.1007/s10549-009-0593-9 1:CAS:528:DC%2BC3cXmtlyhs7w%3D
12. CF Garland ED Gorham SB Mohr WB Grant EL Giovannucci M Lipkin, et al. 2007 Vitamin D and prevention of breast cancer: pooled analysis J Steroid Biochem Mol Biol 103 708 711 17368188 10.1016/j.jsbmb.2006.12.007 1:CAS:528:DC%2BD2sXjt1Wnt7o%3D
13. LJ Peppone AJ Huston ME Reid RN Rosier Y Zakharia DL Trump, et al. 2011 The effect of various vitamin D supplementation regimens in breast cancer patients Breast Cancer Res Treat 127 171 177 21384167 10.1007/s10549-011-1415-4 1:CAS:528:DC%2BC3MXksFegt7g%3D
14. KY Forrest WL Stuhldreher 2011 Prevalence and correlates of vitamin D deficiency in US adults Nutr Res. 31 48 54 21310306 10.1016/j.nutres.2010.12.001 1:CAS:528:DC%2BC3MXhvFegtbY%3D
15. AD Deshpande DB Jeffe J Gnerlich AZ Iqbal A Thummalakunta JA Margenthaler 2009 Racial disparities in breast cancer survival: an analysis by age and stage J Surg Res 153 105 113 19084242 10.1016/j.jss.2008.05.020
16. C Sotiriou L Pusztai 2009 Gene-expression signatures in breast cancer N Engl J Med 360 790 800 19228622 10.1056/NEJMra0801289 1:CAS:528: DC%2BD1MXitFWqs70%3D
17. S Paik S Shak G Tang C Kim J Baker M Cronin, et al. 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826 15591335 10.1056/NEJMoa041588 1:CAS:528: DC%2BD2MXhslymsw%3D%3D
18. Y Cui TE Rohan 2006 Vitamin D, calcium, and breast cancer risk: a review Cancer Epidemiol Biomarkers Prev 15 1427 1437 16896028 10.1158/1055-9965.EPI-06- 0075 1:CAS:528:DC%2BD28XnvVajtrs%3D
19. S Abbas J Chang-Claude J Linseisen 2009 Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study Int J Cancer 124 250 255 18839430 10.1002/ijc.23904 1:CAS:528:DC%2BD1cXhsFahtrfN
20. WB Grant AN Peiris 2010 Possible role of serum 25-hydroxyvitamin D in black-white health disparities in the United States J Am Med Dir Assoc 11 617 628 21029996 10.1016/j.jamda.2010.03.013
21. JP Crowe Jr NH Gordon CA Hubay RR Shenk RM Zollinger DJ Brumberg, et al. 1991 Estrogen receptor determination and long term survival of patients with carcinoma of the breast Surg Gynecol Obstet 173 273 278 1925896
22. KR Bauer M Brown RD Cress CA Parise V Caggiano 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry Cancer 109 1721 1728 17387718 10.1002/cncr.22618
23. KW Colston CM Hansen 2002 Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer Endocr Relat Cancer 9 45 59 11914182 10.1677/erc.0.0090045 1:CAS:528:DC%2BD38XjsVCltb4%3D
24. L Lowe CM Hansen S Senaratne KW Colston 2003 Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells Recent Results Cancer Res 164 99 110 12908448 1:CAS:528:DC%2BD3sXnsVygtLc%3D
25. J Welsh JA Wietzke GM Zinser S Smyczek S Romu E Tribble, et al. 2002 Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer J Steroid Biochem Mol Biol 83 85 92 12650704 10.1016/S0960-0760(02)00277-7 1:CAS:528:DC%2BD3sXitFahsrg%3D
26. CM Kemmis SM Salvador KM Smith J Welsh 2006 Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3 J Nutr 136 887 892 16549446 1:CAS:528:DC%2BD28XjtVOks74%3D
27. G Lazzaro A Agadir W Qing M Poria RR Mehta RM Moriarty, et al. 2000 Induction of differentiation by 1alpha-hydroxyvitamin D(5) in T47D human breast cancer cells and its interaction with vitamin D receptors Eur J Cancer 36 780 786 10762752 10.1016/S0959-8049(00)00016-2 1:CAS:528:DC%2BD3cXitlKktLk%3D
28. M Simboli-Campbell CJ Narvaez M Tenniswood J Welsh 1996 1, 25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells J Steroid Biochem Mol Biol 58 367 376 8903420 10.1016/0960-0760(96)00055-6 1:CAS:528:DyaK28Xmslahtrs%3D
29. DJ Mantell PE Owens NJ Bundred EB Mawer AE Canfield 2000 1 alpha, 25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo Circ Res 87 214 220 10926872 10.1161/01.RES.87.3.214 1:CAS:528:DC%2BD3cXlsFygs7w%3D
30. N Pendas-Franco JM Gonzalez-Sancho Y Suarez O Aguilera A Steinmeyer C Gamallo, et al. 2007 Vitamin D regulates the phenotype of human breast cancer cells Differentiation 75 193 207 17288543 10.1111/j.1432-0436.2006.00131.x 1:CAS:528:DC%2BD2sXjvVylsLw%3D
31. MF Holick 2004 Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis Am J Clin Nutr 79 362 371 14985208 1:CAS:528:DC%2BD2cXhslOht74%3D
32. Z Lagunova AC Porojnicu F Lindberg S Hexeberg J Moan 2009 The dependency of vitamin D status on body mass index, gender, age and season Anticancer Res 29 3713 3720 19667169 1:CAS:528:DC%2BD1MXhtVKku7fF